Skip to content

Is fludrocortisone the same as midodrine?

4 min read

Orthostatic hypotension affects approximately 20% of adults over the age of 65 [1.10.4]. While both are used to treat it, the answer to 'Is fludrocortisone the same as midodrine?' is no; they are fundamentally different medications [1.2.3].

Quick Summary

Fludrocortisone and midodrine are not the same drug. Fludrocortisone is a corticosteroid that increases blood volume, while midodrine is an alpha-1 agonist that constricts blood vessels to raise blood pressure.

Key Points

  • Not the Same: Fludrocortisone is a corticosteroid, while midodrine is an alpha-1 adrenergic agonist [1.2.3].

  • Different Mechanisms: Fludrocortisone increases blood volume by retaining salt and water [1.3.1], whereas midodrine constricts blood vessels [1.4.2].

  • Primary Uses: While both treat orthostatic hypotension, fludrocortisone is also used for adrenal insufficiency conditions like Addison's disease [1.5.3, 1.2.2].

  • Side Effect Profiles: Key side effects for fludrocortisone include swelling and low potassium, while midodrine is known for causing supine hypertension and scalp tingling [1.3.2, 1.9.3].

  • Dosing Regimens Differ: Fludrocortisone is typically taken once daily, while midodrine is dosed three times daily during waking hours to avoid high blood pressure while lying down [1.2.3].

  • Combination Therapy is Possible: The two drugs can be used together in difficult-to-treat cases, targeting two different pathways to raise blood pressure [1.7.4].

  • Medical Supervision is Key: The choice of medication and monitoring for side effects requires careful management by a healthcare professional [1.7.1].

In This Article

Understanding Fludrocortisone and Midodrine

Patients and caregivers often ask, 'Is fludrocortisone the same as midodrine?' because both medications can be prescribed to treat conditions related to low blood pressure, particularly symptomatic orthostatic hypotension [1.6.3, 1.5.2]. However, they belong to different drug classes and work through distinct mechanisms in the body [1.2.3]. Fludrocortisone is a synthetic corticosteroid, specifically a mineralocorticoid, that helps the body retain sodium and water, thereby increasing blood volume [1.3.1, 1.11.1]. In contrast, midodrine is an alpha-1 adrenergic agonist that works by directly tightening or constricting blood vessels to increase vascular tone and elevate blood pressure [1.4.2, 1.12.1]. Understanding these differences is crucial for safe and effective treatment.

What is Fludrocortisone (Florinef)?

Fludrocortisone is a prescription corticosteroid used to treat conditions where the body does not produce enough of its own steroids, such as Addison's disease and salt-losing adrenogenital syndrome [1.5.2, 1.5.3]. It is also commonly used off-label to manage orthostatic hypotension by helping to control the amount of sodium and fluids in the body [1.5.2].

Mechanism of Action

Fludrocortisone mimics the effects of aldosterone, a natural mineralocorticoid hormone [1.3.2]. It acts on the kidneys to increase the reabsorption of sodium and water while promoting the excretion of potassium [1.3.1, 1.5.1]. This leads to an expansion of the intravascular (blood) volume, which helps to raise blood pressure [1.3.2]. Some evidence also suggests it may enhance the sensitivity of blood vessels to naturally circulating vasoconstrictors like norepinephrine [1.3.2].

Common Side Effects

The most common side effects are related to its mechanism of action, including:

  • Swelling of the feet or lower legs (edema) [1.8.1]
  • High blood pressure (hypertension), especially when lying down [1.3.2]
  • Headaches and dizziness [1.8.3]
  • Low potassium levels (hypokalemia) [1.3.2]
  • Weight gain [1.8.4]

What is Midodrine (Proamatine)?

Midodrine is a prescription medication primarily used to treat symptomatic orthostatic hypotension, which is a sudden drop in blood pressure when moving to a standing position [1.6.4]. It is classified as an alpha-adrenergic agonist [1.12.1]. The medication is a prodrug, meaning it is converted into its active form, desglymidodrine, in the body [1.4.2].

Mechanism of Action

The active metabolite, desglymidodrine, stimulates the alpha-1 adrenergic receptors located on the smooth muscle of arteries and veins [1.4.2]. This stimulation causes the blood vessels to constrict (vasoconstriction), which increases peripheral vascular resistance and leads to a rise in blood pressure [1.4.3]. Unlike fludrocortisone, it does not significantly affect blood volume and does not cross the blood-brain barrier, which limits central nervous system side effects [1.4.3].

Common Side Effects

Midodrine's side effects often stem from its vessel-tightening action:

  • Supine hypertension (high blood pressure when lying flat) [1.9.3]
  • Paresthesia (tingling or prickling sensation), often on the scalp [1.9.2]
  • Piloerection (goosebumps) and chills [1.9.2]
  • Urinary urgency, frequency, or retention [1.9.4]
  • Itching, particularly scalp itching [1.9.4]

Fludrocortisone vs. Midodrine Comparison Table

Feature Fludrocortisone Midodrine
Drug Class Corticosteroid (Mineralocorticoid) [1.11.1] Alpha-1 Adrenergic Agonist [1.12.1]
Primary Mechanism Increases sodium and water retention to expand blood volume [1.3.1]. Constricts blood vessels to increase vascular tone [1.4.2].
Primary Indication Addison's disease, salt-losing adrenogenital syndrome [1.5.3]. Symptomatic orthostatic hypotension [1.6.4].
Onset of Action Slower; clinical effect may take several days [1.3.2]. Faster; peak effect about 1 hour after dose [1.4.2].
Dosing Frequency Typically once daily [1.2.3]. Typically three times a day, during upright hours [1.2.3, 1.6.1].
Key Side Effect Fluid retention, swelling, low potassium [1.8.1, 1.3.2]. Supine hypertension, scalp tingling, goosebumps [1.9.3].
Monitoring Blood pressure, electrolytes (especially potassium), weight [1.7.4]. Blood pressure in both standing and lying positions [1.6.4].

Can Fludrocortisone and Midodrine Be Used Together?

Yes, fludrocortisone and midodrine are sometimes prescribed together, particularly in cases of refractory or neurogenic orthostatic hypotension where a single medication is not sufficient [1.2.2, 1.7.4]. This combination therapy targets two different mechanisms to raise blood pressure: fludrocortisone increases blood volume, and midodrine constricts blood vessels [1.7.4]. When used together, close monitoring of blood pressure (both standing and supine), electrolytes, and fluid status is essential due to the increased risk of side effects like supine hypertension [1.7.3, 1.7.4].

Conclusion

To conclude, fludrocortisone and midodrine are not the same medication. They have different drug classifications, mechanisms of action, and side effect profiles. Fludrocortisone, a corticosteroid, works by increasing blood volume, while midodrine, an alpha-1 agonist, works by constricting blood vessels. Although both are effective treatments for orthostatic hypotension, the choice between them—or the decision to use them in combination—depends on the patient's specific condition, comorbidities, and response to treatment. One study found that fludrocortisone was associated with a higher risk of all-cause hospitalizations compared to midodrine, especially in patients with a history of congestive heart failure [1.2.5]. As with any prescription medication, a healthcare provider must make the determination of which treatment is most appropriate.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any decisions about your health or treatment.

An Authoritative Outbound Link

Frequently Asked Questions

No. Fludrocortisone is in the corticosteroid drug class (specifically, a mineralocorticoid) [1.11.1]. Midodrine is in the alpha-adrenergic agonist drug class [1.12.1].

Midodrine works faster, with its peak effect occurring about 1 to 2 hours after taking a dose [1.4.2]. Fludrocortisone has a much slower onset, and a clinical effect may not be seen for several days [1.3.2].

No, it is not recommended. The last daily dose of midodrine should be taken at least 3 to 4 hours before bedtime to avoid the risk of supine hypertension (high blood pressure while lying down) [1.6.4, 1.9.2].

Common side effects of fludrocortisone are related to fluid and electrolyte imbalance, such as swelling in the hands or feet (edema), high blood pressure, and low potassium levels [1.8.1, 1.3.2].

The most potentially serious side effect of midodrine is supine hypertension (high blood pressure when lying down). This risk is why the medication should not be taken close to bedtime [1.9.3, 1.6.4].

Yes, they can be prescribed together, especially for severe or refractory orthostatic hypotension. This allows for targeting two different mechanisms to raise blood pressure, but requires close medical supervision [1.7.4].

Your doctor may advise you to monitor your salt intake while taking fludrocortisone to help minimize water retention [1.5.1]. You may also need to ensure adequate potassium intake, as the drug can cause potassium loss [1.3.3].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.